Modulation of peroxidation and pro-inflammatory parameters, as well as the inactivation of apoptosis-related components, such as Bcl-2, Bax, and caspase-3, have been shown to benefit patients with T2DM by using nutrition interventions [10,11,12]. The gene discussed is BCL2; the disease is type 2 diabetes mellitus.